Skip to content

Investigator

Linda S Lloyd

STRESS THERAPEUTICS, INC. · funded by NIA, NIAAA

Companies
2

Resolved onto their grants.

Grants
4

Federal awards on file.

Non-dilutive funding
$3.1M

Summed across those awards.

First award
Sep 1, 2019

Latest Jun 1, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R43

    Lead Optimization of a Therapeutic Candidate for Alzheimer’s Disease

    $350k

    Jun 1, 2025NIASTRESS THERAPEUTICS, INC.NIH RePORTER · 11077619 (opens the source filing in a new tab)

  2. U43

    Investigational New Drug (IND)-enabling Study for a New Therapeutic for Alcohol Use Disorder (AUD)

    $999k

    May 15, 2025NIAAASTRESS THERAPEUTICS, INC.NIH RePORTER · 11062330 (opens the source filing in a new tab)

  3. U43

    Investigational New Drug (IND)-enabling Study for a New Therapeutic for Alcohol Use Disorder (AUD)

    $995k

    May 15, 2025NIAAASTRESS THERAPEUTICS, INC.NIH RePORTER · 11332743 (opens the source filing in a new tab)

  4. R44

    Novel therapeutic for HPA hyperactivity

    $717k

    Sep 1, 2019NIAAASTRESS THERAPEUTICS, INC.NIH RePORTER · 11105954 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources